Malabsorption is a major contributor to underweight in Crohn's disease patients in remission

被引:55
|
作者
Vaisman, Nachum [1 ]
Dotan, Iris
Halack, Aharon
Niv, Eva
机构
[1] Tel Aviv Univ, Sackler Fac Med, Unit Clin Nutr, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Inflammatory Bowel Dis Serv, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Dept Gastroenterol & Liver Dis, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
关键词
Crohn's disease; resting energy expenditure; malabsorption;
D O I
10.1016/j.nut.2006.05.013
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: Undernutrition has been reported in 65-75% of patients with Crohn's disease. The present study aimed at identifying the relative contribution of malnutrition-causing factors in patients with Crohn's disease in remission. Methods: Sixteen patients with Crohn's disease (age 19-57 y) in remission (Crohn's Activity Disease Index < 150) were included in the study. Their weight was stable for > 3 mo and they were off steroids. They all completed 3-d food records and concomitantly collected stools. Self-reported food records were analyzed and energy content in stools was determined by a direct bomb calorimeter. Resting energy expenditure (REE) was studied by indirect calorimetry and body composition by dual-energy X-ray absorptiometry. The study cohort was divided into two groups, with a body mass index (BMI) equal to 18.5 kg/m(2) serving as a cutoff point. Results: Subjects with lower BMIs tended to have less lean body mass (P = 0.006), less bone mineral density (P = 0.006), and lower REE (P = 0.003). No correlation was found between BMI and energy intake but the percentage of malabsorption was negatively correlated with BMI (P 0.07). When dividing the study based on a BMI of 18.5 kg/m(2), no difference was found in caloric intake or REE between groups but subjects with lower BMIs had significant prominent malabsorption compared with the others (21.1 +/- 9.8% versus 11.7 +/- 3.5%, P = 0.015). Conclusion: In the presence of similar energy intake, REE does not seem to contribute to lower BMI, although nutrient malabsorption is higher in malnourished patients with Crohn's disease in remission. We suggest that malabsorption be evaluated in patients with Crohn's disease who fail to gain weight during disease remission to establish their extra caloric requirements. (c) 2006 Elsevier Inc. All tights reserved.
引用
收藏
页码:855 / 859
页数:5
相关论文
共 50 条
  • [21] Serum proteomics predict endoscopic remission in patients with Crohn's Disease
    Alsoud, D.
    Sudhakar, P.
    Sabino, J.
    Ferrante, M.
    Verstockt, B.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S046 - S046
  • [22] Anxiety and Depression Symptoms in Crohn's Disease (CD) Patients in Remission
    Barreiro, Manuel
    Iglesias, Marta
    Figueiras, Adolfo
    Vazquez, Isabel
    Nieto, Laura
    Lorenzo, Aurelio
    Dominguez-Munoz, Enrique
    GASTROENTEROLOGY, 2009, 136 (05) : A360 - A360
  • [23] Serum Adalimumab Concentration and Clinical Remission in Patients with Crohn's Disease
    Chiu, Yi-Lin
    Rubin, David T.
    Vermeire, Severine
    Louis, Edouard
    Robinson, Anne M.
    Lomax, Kathleen G.
    Pollack, Paul F.
    Paulson, Susan K.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : 1112 - 1122
  • [24] Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission
    Minderhoud, Itta M.
    Oldenburg, Bas
    Schipper, Marguerite E. I.
    Ter Linde, Jose J. M.
    Samsom, Melvin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (06) : 714 - 720
  • [25] Prediction of achieving remission in Crohn's disease patients by abdominal Imaging
    Meringer, H.
    Tzadok, R.
    Mercer, D.
    Handler, M.
    Barnes, S.
    Waterman, M.
    Abadi, S.
    Yehuda, R. Margalit
    Kopylov, U.
    Amitai, M. M.
    Shitrit, A. Bar-Gil
    Sheynkman, G.
    Zittan, E.
    Maharshak, N.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S528 - S529
  • [26] Cardiac and autonomic function in patients with Crohn's disease during remission
    Zawadka-Kunikowska, Monika
    Slomko, Joanna
    Klopocka, Maria
    Liebert, Ariel
    Tafil-Klawe, Malgorzata
    Klawe, Jacek J.
    Newton, Julia L.
    Zalewski, Pawel
    ADVANCES IN MEDICAL SCIENCES, 2018, 63 (02): : 334 - 340
  • [27] Commentary: predicting relapse in Crohn's disease patients in remission with biologics
    Andrews, J. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) : 497 - 498
  • [28] How should we follow the Crohn's disease patients in remission?
    Yonal, Oya
    Kaymakoglu, Sabahattin
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21 (01): : 97 - 99
  • [29] Patients With Crohn's Disease and Ileostomy Can Achieve Remission With Upadacitinib
    Loeb, Lauren P.
    Farraye, Francis A.
    Kinnucan, Jami A.
    Crosby, Sheena K.
    Picco, Michael F.
    Hashash, Jana G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S878 - S879
  • [30] Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World
    Ahmad, Harris
    Click, Benjamin
    Morris, Heather L.
    Crawford, Julie M.
    Choi, Jiyoon
    Long, Millie D.
    TARGET IBD Investigators
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2025, 59 (03) : 245 - 250